Unternehmen
ADVANCED MARKER DISCOVERY SL
ADVANCED MARKER DISCOVERY SL – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
De-Risking the drug discovery process of Oncology and Metabolic diseases
Excellence: Vitala Technologies brings together Organ-on-Chip (OoC), hyperpolarized magnetic resonance spectroscopic imaging (HP… Beitrag ansehen →
Projekt
→
Advanced biomarker discovery for earlier diagnosis and improved prognosis of NAFLD stages via high resolution mass spectrometry.
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of nearly 25% i.e., affects one quarter of the adult population… Beitrag ansehen →
Projekt
→
Advanced human models of the heart to understand cardiovascular disease
Cardiovascular diseases (CVD) are the cause of the highest mortality and morbidity rates worldwide and are expected to increase i… Beitrag ansehen →
Projekt
→
Perovskite triple and quadruple junction solar cells
Metal halide perovskite solar cells have advanced from an intriguing scientific discovery into a viable option for future renewab… Beitrag ansehen →
Projekt
→
Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations
Rare Eye Diseases (REDs) are a major cause of visual impairment and blindness in Europe, affecting patients of all ages. The REST… Beitrag ansehen →
Projekt
→
New generation of substrates to harness the full power of microorganisms
Bac3Gel is a biotech company that develops and distributes advanced substrates to harness the full power of microorganisms. Bac3G… Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- Disruptive and high accuracy test for early colorectal cancer detection in blood AMADIX is a leading molecular diagnostics company, led by Rocío Arroyo, focused on liquid biopsy, developing… →
- FCAECC Fellowship programme for talented researchers in cancer The Scientific Foundation of the Spanish Association against Cancer (from now on, FCAECC) is a philanthropic… →